Literature DB >> 33408594

Artificial Intelligence and its future potential in lung cancer screening.

Christopher Joy Mathew1, Ashwini Maria David2, Chris Mariya Joy Mathew3.   

Abstract

Artificial intelligence (AI) simulates intelligent behavior as well as critical thinking comparable to a human being and can be used to analyze and interpret complex medical data. The application of AI in imaging diagnostics reduces the burden of radiologists and increases the sensitivity of lung cancer screening so that the morbidity and mortality associated with lung cancer can be decreased. In this article, we have tried to evaluate the role of artificial intelligence in lung cancer screening, as well as the future potential and efficiency of AI in the classification of nodules. The relevant studies between 2010-2020 were selected from the PubMed database after excluding animal studies and were analyzed for the contribution of AI. Techniques such as deep learning and machine learning allow automatic characterization and classification of nodules with high precision and promise an advanced lung cancer screening method in the future. Even though several combination models with high performance have been proposed, an effectively validated model for routine use still needs to be improvised. Combining the performance of artificial intelligence with a radiologist's expertise offers a successful outcome with higher accuracy. Thus, we can conclude that higher sensitivity, specificity, and accuracy of lung cancer screening and classification of nodules is possible through the integration of artificial intelligence and radiology. The validation of models and further research is to be carried out to determine the feasibility of this integration.
Copyright © 2020 Joy Mathew et al.

Entities:  

Keywords:  artificial intelligence; artificial intelligence and lung cancer; artificial intelligence in radiology; computer-aided diagnosis; convolutional neural networks (CNN); detection of cancer; low-dose computed tomography; lung cancer screening; lung neoplasms; machine learning

Year:  2020        PMID: 33408594      PMCID: PMC7783473          DOI: 10.17179/excli2020-3095

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


  5 in total

Review 1.  Emerging Approaches to Complement Low-Dose Computerized Tomography for Lung Cancer Screening: A Narrative Review.

Authors:  Bradley Maller; Tawee Tanvetyanon
Journal:  Cureus       Date:  2022-07-26

2.  Eyelid carcinomas: Tumor aggressiveness tendencies for smokers compared to non-smokers.

Authors:  Razvan Mercut; Irina Maria Mercut; Adina Dorina Glodeanu; Mihaela Ionescu; Adina Turcu; Alin Stefanescu-Dima; Marius Eugen Ciurea
Journal:  Exp Ther Med       Date:  2022-01-21       Impact factor: 2.447

3.  [Chinese Experts Consensus on Artificial Intelligence Assisted Management for 
Pulmonary Nodule (2022 Version)].

Authors: 
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-03-28

Review 4.  Current treatments for non-small cell lung cancer.

Authors:  Qianqian Guo; Liwei Liu; Zelong Chen; Yannan Fan; Yang Zhou; Ziqiao Yuan; Wenzhou Zhang
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

5.  Mapping intellectual structures and research hotspots in the application of artificial intelligence in cancer: A bibliometric analysis.

Authors:  Peng-Fei Lyu; Yu Wang; Qing-Xiang Meng; Ping-Ming Fan; Ke Ma; Sha Xiao; Xun-Chen Cao; Guang-Xun Lin; Si-Yuan Dong
Journal:  Front Oncol       Date:  2022-09-22       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.